Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo - Wikidata - wikimedia - TriplyDB

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

http://www.wikidata.org/entity/Q24794301

about

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism Recent advances in understanding vitiligo Increased Risk of Metabolic Syndrome in Patients with Vitiligo.Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo Advances in Vitiligo: An Update on Medical and Surgical Treatments.A Comparison of Betamethasone Valerate 0.1% Cream Twice Daily Plus Oral Simvastatin Versus Betamethasone Valerate 0.1% Cream Alone in the Treatment of Vitiligo Patients Understanding mechanisms of autoimmunity through translational research in vitiligo.Understanding autoimmunity of vitiligo and alopecia areata.Vitiligo Pathogenesis and Emerging Treatments.Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo.A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo.

P2860

Q24603957-EBDB7373-03B1-4E5D-9149-4EF701A0858C Q28078377-5FD4BB82-7242-45E1-807A-D74B29971E23 Q33745258-195AF169-BC1D-4610-AE54-9A69D6D2800D Q35196424-7892A5CA-D783-4F66-9ABB-B330018E9F61 Q37634313-7C5D9F4A-A4AE-479B-9404-6BA66C8A41DC Q37743574-ECFE9D20-D73D-4E41-BD13-E188070FEA80 Q38808662-40019DFC-D75B-4A2A-882B-1871223242ED Q38837287-78C824F9-5C92-488F-AA34-8D554CB3DCDA Q39187086-65F59EDE-8B74-4B0A-B2D5-522236B045C3 Q43116514-6A81F34A-ECCF-433D-8033-842314FA2503 Q51255116-18488F02-64DB-44DF-A2A8-9F7194B87C05

P2860

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

http://www.wikidata.org/entity/Q24794301

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

@ast

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

@en

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

@nl

type

label

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

@ast

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

@en

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

@nl

prefLabel

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

@ast

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

@en

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

@nl

P1433

Q24794301-E30B15F5-7FEA-4E5A-BBD5-D519768A0EC2

P1476

Q24794301-D8BEA458-90DE-43EF-B250-8C0102404955

P2093

Q24794301-05BABFF3-9313-4578-81D2-9D724EA593C1

Q24794301-77801317-E18A-41DF-B27A-79C271531552

Q24794301-A3D75EAB-DFC1-4819-AB28-A8E5BDC33FF0

Q24794301-B393CAF5-7671-450D-8473-DBA3802C8A2E

Q24794301-C84D2569-4D2E-496F-8111-D90B7C60D9E6

P2860

Q24794301-055E6B0E-CB46-438D-B17F-F587DA9AD802

Q24794301-14834C31-7573-446A-9BFB-F604CEF0B916

Q24794301-32316A44-875A-4157-BC74-A196E010D4CB

Q24794301-38D82B89-69F8-4BC5-A06A-4C395D399B33

Q24794301-4BAD307F-646A-49F9-802D-49CEB83D1784

Q24794301-4D0BB5B1-A92F-4279-9E3C-B3F3E876FB16

Q24794301-794E9CA0-4841-495A-8E6E-1AD1B8C35339

Q24794301-B6C75DE6-15F8-4796-9564-CA341148E7F9

Q24794301-BE927FE1-643D-4FE7-A898-4F0837B84192

Q24794301-E6436551-D12A-490C-82EF-89334D54B88F

P2888

Q24794301-4392B0D5-9A1F-427D-A985-EE9E0B628A92

P304

Q24794301-0ACE576B-723C-4E97-9E1E-23B68D6338FF

P31

Q24794301-D6E1F664-7907-4D26-8744-4DF53C43F196

P3181

Q24794301-0218B823-260F-4176-82ED-9FEA06EAECBC

P356

Q24794301-B4E874B3-43FA-44EC-9DF5-0C8FF19581DD

P407

Q24794301-919724F5-4FCF-43A0-AC3E-B58E557D1182

P433

Q24794301-85963F85-45BF-4BDA-AF47-36719BD21669

P478

Q24794301-5B56D576-8A04-40BF-A54F-4418AF136847

P577

Q24794301-A9C15144-81A0-4892-914E-99A6E3880509

P5875

Q24794301-F3F65B35-900B-499B-9BA6-A141016A174E

P6179

Q24794301-58C410A8-6D45-4CC9-BAB3-4C04B4D31B31

P698

Q24794301-157A9643-E893-4A29-9111-D08AF90AE304

P921

Q24794301-C48FCB39-BD54-4A30-A0E9-286E48A32808

P932

Q24794301-CD349976-7AB4-4493-94C9-2F5F2102A492

P3181

P356

P1433

Lipids in Health and Disease

P1476

Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo

@en

P2093

Claude Gagné

http://www.w3.org/2001/XMLSchema#string

Jean Bergeron

http://www.w3.org/2001/XMLSchema#string

Jean Jobin

http://www.w3.org/2001/XMLSchema#string

Martin Noël

http://www.w3.org/2001/XMLSchema#string

Paul Poirier

http://www.w3.org/2001/XMLSchema#string

P2860

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells.

Current perspectives on statins.

Autoimmune aspects of vitiligo.

Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis.

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial.

Antibodies to normal human melanocytes in vitiligo.

Effects of pravastatin on chronic rejection of rat cardiac allografts.

Effect of pravastatin on outcomes after cardiac transplantation.

Statins as immunosuppressive agents.

P2888

P304

7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3656502

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1476-511X-3-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2004-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8570458

http://www.w3.org/2001/XMLSchema#string

P6179

1041281693

http://www.w3.org/2001/XMLSchema#string

P698

15134579

http://www.w3.org/2001/XMLSchema#string

P921

clinical chemistry

P932

425594

http://www.w3.org/2001/XMLSchema#string